HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daria Mochly-Rosen Selected Research

Heart Diseases (Heart Disease)

3/2015New therapeutics to modulate mitochondrial dynamics and mitophagy in cardiac diseases.
11/2011ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance.
10/2010Mitochondrial aldehyde dehydrogenase and cardiac diseases.
1/2008PKC isozymes in chronic cardiac disease: possible therapeutic targets?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daria Mochly-Rosen Research Topics

Disease

31Ischemia
01/2023 - 06/2002
21Myocardial Infarction
02/2022 - 08/2006
19Neoplasms (Cancer)
11/2023 - 05/2002
16Heart Failure
11/2023 - 10/2002
16Reperfusion Injury
02/2022 - 08/2003
12Mitochondrial Diseases (Mitochondrial Disease)
11/2023 - 11/2011
11Infarction (Infarctions)
10/2013 - 11/2003
10Inflammation (Inflammations)
01/2022 - 10/2007
8Pain (Aches)
11/2021 - 05/2004
6Flushing
01/2023 - 02/2010
6Glucosephosphate Dehydrogenase Deficiency
01/2022 - 06/2016
6Hypertension (High Blood Pressure)
07/2012 - 10/2002
6Cardiomegaly (Heart Hypertrophy)
10/2011 - 10/2002
5COVID-19
01/2023 - 01/2021
5Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2012
5Huntington Disease (Huntington's Disease)
01/2018 - 12/2013
5Stroke (Strokes)
01/2017 - 07/2003
4Sepsis (Septicemia)
01/2023 - 01/2019
4Fibrosis (Cirrhosis)
03/2021 - 01/2008
4Heart Diseases (Heart Disease)
03/2015 - 01/2008
4Hypertrophy
10/2011 - 10/2002
4Brain Ischemia (Cerebral Ischemia)
12/2005 - 07/2003
3Alzheimer Disease (Alzheimer's Disease)
01/2023 - 12/2016
3Hemolytic Anemia
01/2022 - 10/2018
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019 - 01/2014
3Myocardial Ischemia (Ischemic Heart Diseases)
09/2013 - 02/2007
3Coronary Artery Disease (Coronary Atherosclerosis)
05/2005 - 01/2004
2Cardiac Arrhythmias (Arrythmia)
01/2023 - 12/2008
2Ischemic Stroke
10/2022 - 12/2016
2Carcinogenesis
02/2022 - 05/2002
2Communicable Diseases (Infectious Diseases)
01/2022 - 01/2021
2Atrial Fibrillation
01/2021 - 12/2016
2Brain Diseases (Brain Disorder)
01/2020 - 01/2011
2Cardiomyopathies (Cardiomyopathy)
01/2019 - 01/2015
2Xerostomia
12/2018 - 08/2013
2Head and Neck Neoplasms (Head and Neck Cancer)
12/2018 - 08/2013
2Squamous Cell Carcinoma of Head and Neck
01/2018 - 08/2017
2Diabetes Complications
01/2018 - 12/2012
2Cardiotoxicity
01/2018 - 11/2011
2Parkinson Disease (Parkinson's Disease)
12/2016 - 02/2013
2Heart Arrest (Cardiac Arrest)
01/2016 - 06/2005
2Brain Injuries (Brain Injury)
06/2013 - 07/2003
2Angina Pectoris
01/2012 - 11/2011
2Prostatic Neoplasms (Prostate Cancer)
06/2011 - 08/2008
2Atherosclerosis
01/2010 - 01/2008
2Hyperglycemia
01/2009 - 10/2005
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
12/2008 - 10/2002

Drug/Important Bio-Agent (IBA)

23Protein Kinase CIBA
10/2011 - 06/2002
22AldehydesIBA
11/2023 - 09/2008
21Peptides (Polypeptides)IBA
01/2023 - 08/2003
21Proteins (Proteins, Gene)FDA Link
01/2023 - 05/2002
20Aldehyde DehydrogenaseIBA
01/2023 - 02/2009
17IsoenzymesIBA
09/2013 - 05/2002
13EnzymesIBA
01/2023 - 07/2005
9Phosphotransferases (Kinase)IBA
02/2022 - 11/2003
74-hydroxy-2-nonenal (4-hydroxynonenal)IBA
11/2023 - 04/2010
7Ethanol (Ethyl Alcohol)IBA
12/2019 - 08/2005
6Glucose (Dextrose)FDA LinkGeneric
01/2023 - 07/2004
6delta proteinIBA
02/2022 - 11/2003
6Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
01/2022 - 06/2016
6Protein Kinases (Protein Kinase)IBA
06/2013 - 11/2004
6Protein Kinase C-epsilonIBA
10/2005 - 05/2002
5AcetaldehydeIBA
11/2023 - 02/2010
5Amino AcidsFDA Link
02/2022 - 08/2006
5SaltsIBA
12/2008 - 10/2002
4VaccinesIBA
01/2023 - 01/2021
4Oxidoreductases (Dehydrogenase)IBA
10/2022 - 07/2005
4Oxygen (Dioxygen)IBA
06/2005 - 12/2003
3Dynamins (Dynamin)IBA
01/2023 - 01/2019
3LipopolysaccharidesIBA
01/2023 - 01/2020
3IgYIBA
12/2022 - 01/2021
3Protein Isoforms (Isoforms)IBA
10/2022 - 06/2002
3Protein Kinase C-deltaIBA
02/2022 - 08/2004
3Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2008
3Adenosine Triphosphate (ATP)IBA
12/2018 - 10/2013
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 02/2013
3polyglutamineIBA
11/2016 - 01/2014
3Huntingtin ProteinIBA
11/2016 - 12/2013
3Neuroprotective AgentsIBA
01/2015 - 12/2005
3Mitochondrial Aldehyde DehydrogenaseIBA
09/2014 - 10/2010
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2012 - 01/2008
2BilirubinIBA
10/2018 - 06/2016
2Cisplatin (Platino)FDA LinkGeneric
08/2017 - 05/2017
2CalciumIBA
01/2016 - 01/2016
2Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA
10/2015 - 06/2013
2Therapeutic UsesIBA
01/2015 - 12/2008
2Analgesics (Analgesic Drugs)IBA
08/2014 - 01/2014
2Opioid Analgesics (Opioids)IBA
01/2014 - 07/2004
2BradykininIBA
09/2013 - 04/2009
2Nitroglycerin (Dynamite)FDA LinkGeneric
01/2012 - 11/2011
2Formaldehyde (Formol)FDA Link
08/2011 - 05/2004
2tat Gene Products (tat Protein)IBA
10/2010 - 08/2003
2Creatine Kinase (Creatine Phosphokinase)IBA
02/2009 - 08/2003
2Receptors for Activated C KinaseIBA
01/2009 - 10/2005
2dimemorfan (AT 17)IBA
06/2008 - 10/2002
2Cytochromes c (Cytochrome c)IBA
08/2007 - 06/2005

Therapy/Procedure

12Therapeutics
11/2023 - 01/2007
3Radiotherapy
12/2018 - 07/2012
2Intraperitoneal Injections
02/2009 - 05/2007
2Heart Transplantation (Grafting, Heart)
10/2007 - 09/2004